Published in:
Open Access
01-12-2021 | Cystic Fibrosis | Letter to the Editor
COVID-19 lockdown beneficial effects on lung function in a cohort of cystic fibrosis patients
Authors:
Alessia Giuseppina Servidio, Giulia Capata, Laura Levantino, Guglielmo Riccio, Sarah Contorno, Egidio Barbi, Massimo Maschio
Published in:
Italian Journal of Pediatrics
|
Issue 1/2021
Login to get access
Excerpt
In December 2019, an infectious disease, caused by a novel coronavirus, emerged in Wuhan City, China. The disease was later named coronavirus disease 2019 (COVID-19) and the virus which causes it was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To limit the spread of the COVID-19 in our country, the Italian Government imposed the first urgent measures on February 23rd, 2020 and then a national quarantine from March 9th, 2020 to May 4th, 2020 restricting the free movement of the entire population to the essential minimum. The presence of chronic diseases has been considered one of the main risk factors for COVID-19-related morbidity and mortality. Cystic fibrosis (CF) is a chronic and life-shortening disease affecting up to 1 in 2000 to 3000 live births among Caucasian population. As respiratory complications are the major cause of morbidity and mortality in CF patients, earlier preventive measures, e.g. home isolation, self-monitoring, reinforcing adherence to therapy, were strongly recommended to reduce the risk of COVID-19 infection in these patients [
1]. To avoid unnecessary hospital visits and viral spread, telemedicine was encouraged, routine visits were cancelled and pulmonary function testing was performed only if therapeutic decisions were essential [
2]. …